Effect of Food on the Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mgA Randomized, Open-Label, Crossover, Single-Centre Study

被引:0
|
作者
Mona Darwish
Fang Xie
机构
[1] Cephalon,Department of Clinical Pharmacology
[2] Inc.,Biometrics Department
[3] Cephalon,undefined
[4] Inc.,undefined
来源
关键词
Oxybutynin; Food Effect; Tizanidine; Study Drug Administration; Aphthous Stomatitis;
D O I
暂无
中图分类号
学科分类号
摘要
Background and objective: Food can alter the bioavailability of the controlled-release formulations of many different drugs. This study assessed the effect of food on the pharmacokinetics of once-daily cyclobenzaprine extended-release (CER) in healthy adult subjects.
引用
收藏
页码:145 / 152
页数:7
相关论文
共 50 条
  • [41] Pharmacokinetics of Extended-Release Dipyridamole following Administration through a Gastrostomy TubeAn Open-Label, Case-Control, Two-Centre Study
    Leonardo M. Batista
    David Crandell
    Fabricio O. Lima
    David M. Greer
    Clinical Drug Investigation, 2010, 30 : 483 - 488
  • [42] Efficacy and tolerability of once-daily OROS® hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain:: Results of a 6-week, randomized, open-label, noninferiority analysis
    Hale, Martin
    Tudor, Lulia Cristina
    Khanna, Sarita
    Thipphawong, John
    CLINICAL THERAPEUTICS, 2007, 29 (05) : 874 - 888
  • [43] A single-center, open-label, randomized cross-over study to evaluate the pharmacokinetics and bioavailability of once-daily prolonged-release formulations of tacrolimus in de novo liver transplant recipients
    Herden, Uta
    Sterneck, Martina
    Buchholz, Bettina M.
    Achilles, Eike G.
    Ott, Armin
    Fischer, Lutz
    IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (04) : 1771 - 1780
  • [44] Oral Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users
    Harris, Stephen C.
    Cipriano, Alessandra
    Colucci, Salvatore V.
    Kapil, Ram P.
    Geoffroy, Pierre
    Hopyan, Talar
    Levy-Cooperman, Naama
    PAIN MEDICINE, 2017, 18 (07) : 1278 - 1291
  • [45] Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users
    Harris, Stephen C.
    Cipriano, Alessandra
    Colucci, Salvatore V.
    Kapil, Ram P.
    Geoffroy, Pierre
    Hopyan, Talar
    Levy-Cooperman, Naama
    PAIN MEDICINE, 2016, 17 (05) : 820 - 831
  • [46] Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediateand extended-release formulations in healthy subjects
    Marier, Jean-Francois
    Ducharme, Murray P.
    DiMarco, Marika
    Di Spirito, Mike
    Morelli, Gaetano
    Tippabhotla, Sudhakar K.
    Badri, N.
    Rampal, Ashok
    Monif, Tausif
    CLINICAL THERAPEUTICS, 2006, 28 (12) : 2070 - 2080
  • [47] Long-term, Open-label Study of Once-daily Ropinirole Prolonged Release in Early Parkinson's Disease
    Hauser, Robert A.
    Reichmann, Heinz
    Lew, Mark
    Asgharian, Afsaneh
    Makumi, Clare
    Shulman, Kenneth J.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2011, 121 (05) : 246 - 253
  • [48] Safety and Tolerability of Extended-Release Memantine (Once Daily, 28 mg) in Patients with Moderate to Severe Alzheimer's Disease: An Open-Label Extension Study
    Alva, Gustavo
    Grossberg, George T.
    Manes, Facundo
    Allegri, Ricardo
    Guttierez Robledo, Luis Miguel
    Gloger, Sergio
    Xie, Lei
    Jia, Xinwei Daniel
    Perhach, James L.
    Graham, Stephen M.
    NEUROLOGY, 2010, 74 (09) : A394 - A395
  • [49] A Single-Dose, Two-Way Crossover, Open-Label Bioequivalence Study of an Amphetamine Extended-Release Oral Suspension in Healthy Adults
    Sikes, Carolyn
    Stark, Jeffrey G.
    McMahen, Russ
    Engelking, Dorothy
    JOURNAL OF ATTENTION DISORDERS, 2020, 24 (03) : 414 - 419
  • [50] Bioequivalence of Single and Multiple Doses of Venlafaxine Extended-Release Tablets and Capsules in the Fasted and Fed States: Four Open-Label, Randomized Crossover Trials in Healthy Volunteers
    Wright, Clinton W.
    Aikman, Mark S.
    Werts, Erica
    Seabolt, Julia
    Haeusler, Jean-Marc C.
    CLINICAL THERAPEUTICS, 2009, 31 (11) : 2722 - 2734